While this variant modulates the binding affinity between the transcription factors Sp1 and NFkB and the MDM2 promoter, and elevates MDM2 transcription16, the only previous study assessing its potential effect on cancer risk included 45 patients diagnosed with endometrial cancer and a similar number of controls16. Here, NFKB1 is linked to endometrial cancer.